Enalapril decreases rat plasma concentration of TMAO, a gut bacteria-derived cardiovascular marker

References

• Bae, S., et al., 2014. Plasma choline metabolites and colorectal cancer risk in the Women’s Health Initiative Observational Study. Cancer research, 74 (24), 7442–7452.
   PubMed Web of Science ®Google Scholar
• Barreto, F.C., et al., and European Uremic Toxin Work, G., 2009. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clinical journal of the American society of nephrology, 4 (10), 1551–1558.
   PubMed Web of Science ®Google Scholar
• Benedetto, U., et al., 2008. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting. Annals of thoracic surgery, 86 (4), 1160–1165.
   PubMed Web of Science ®Google Scholar
• Brown, J.M. and Hazen, S.L., 2017. Targeting of microbe-derived metabolites to improve human health: the next frontier for drug discovery. The journal of biological chemistry, 292 (21), 8560–8568.
   PubMed Web of Science ®Google Scholar
• Caporaso, J.G., et al., 2010. QIIME allows analysis of high-throughput community sequencing data. Nature methods, 7 (5), 335–336.
   PubMed Web of Science ®Google Scholar
• Craciun, S. and Balskus, E.P., 2012. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proceedings of the national academy of sciences of the United States of America, 109 (52), 21307–21312.
   PubMed Web of Science ®Google Scholar
• Dambrova, M., et al., 2016. Diabetes is associated with higher trimethylamine N-oxide plasma levels. Experimental and clinical endocrinology & diabetes, 124 (4), 251–256.
   PubMed Web of Science ®Google Scholar
• Dou, L., et al., 2015. The cardiovascular effect of the uremic solute indole-3 acetic acid. Journal of the American society of nephrology, 26 (4), 876–887.
   PubMed Web of Science ®Google Scholar
• Evered, M.D. and Robinson, M.M., 1984. Increased or decreased thirst caused by inhibition of angiotensin-converting enzyme in the rat. The journal of physiology, 348, 573–588.
   PubMed Web of Science ®Google Scholar
• Ferrario, C.M. and Mullick, A.E., 2017. Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease. Pharmacological research, 125 (Pt A), 57–71.
   Web of Science ®Google Scholar
• Gonzalez Bosc, L., et al., 2000. Effect of chronic angiotensin II inhibition on the cardiovascular system of the normal rat. American journal of hypertension, 13 (12), 1301–1307.
   PubMed Web of Science ®Google Scholar
• Guertin, K.A., et al., 2017. Serum trimethylamine N-oxide, carnitine, choline, and betaine in relation to colorectal cancer risk in the alpha tocopherol, beta carotene Cancer Prevention Study. Cancer epidemiology biomarkers & prevention, 26 (6), 945–952.
   PubMed Web of Science ®Google Scholar
• Huc, T., et al., 2017. Indole and indoxyl sulfate, gut bacteria metabolites of tryptophan, change arterial blood pressure via peripheral and central mechanisms in rats. Pharmacological research, [Epub ahead of print]. doi: 10.1016/j.phrs.2017.12.025
   PubMed Web of Science ®Google Scholar
• Jaworska, K., et al., 2017. Hypertension in rats is associated with an increased permeability of the colon to TMA, a gut bacteria metabolite. PLoS One, 12 (12), e0189310.
   PubMed Web of Science ®Google Scholar
• Koeth, R.A., et al., 2013. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nature medicine, 19 (5), 576–585.
   PubMed Web of Science ®Google Scholar
• Korner, P.I. and Bobik, A., 1995. Cardiovascular development after enalapril in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension, 25 (4 Pt 1), 610–619.
   Google Scholar
• Lekawanvijit, S., et al., 2010. Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? European heart journal, 31 (14), 1771–1779.
   PubMed Web of Science ®Google Scholar
• Li, X.S., et al., 2017. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. European heart journal, 38 (11), 814–824.
   PubMed Web of Science ®Google Scholar
• Makrecka-Kuka, M., et al., 2017. Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria. Toxicology letters, 267, 32–38.
   PubMed Web of Science ®Google Scholar
• Mercier, K., Smith, H., and Biederman, J., 2014. Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors. Primary care, 41 (4), 765–778.
   PubMed Web of Science ®Google Scholar
• Miyake, T., et al., 2017. Involvement of organic cation transporters in the kinetics of trimethylamine N-oxide. Journal of pharmaceutical sciences, 106 (9), 2542–2550.
   PubMed Web of Science ®Google Scholar
• Nazzal, L., et al., 2017. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease. Nephrology dialysis transplantation, 32, 1809–1817.
   PubMed Web of Science ®Google Scholar
• Nowinski, A. and Ufnal, M., 2018. Trimethylamine N-oxide: a harmful, protective or diagnostic marker in lifestyle diseases? Nutrition, 46, 7–12.
   PubMed Web of Science ®Google Scholar
• Romano, K.A., et al., 2015. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio, 6 (2), e02481.
   PubMed Web of Science ®Google Scholar
• Senthong, V., et al., 2016a. Trimethylamine N-oxide and mortality risk in patients with peripheral artery disease. Journal of the American heart association, 5 (10), e004237.
   PubMed Web of Science ®Google Scholar
• Senthong, V., et al., 2016b. Intestinal microbiota-generated metabolite trimethylamine-N-oxide and 5-year mortality risk in stable coronary artery disease: the contributory role of intestinal microbiota in a COURAGE-like patient cohort. Journal of the American heart association, 5 (6), e002816.
   PubMed Web of Science ®Google Scholar
• Sikora, M., et al., 2016. Repeated restraint stress produces acute and chronic changes in hemodynamic parameters in rats. Stress, 19 (6), 621–629.
   PubMed Web of Science ®Google Scholar
• Somero, G.N., 1986. From dogfish to dogs: trimethylamines protect proteins from urea. Physiology, 1 (1), 9–12.
   Google Scholar
• Tang, W.H., et al., 2017. Increased Trimethylamine N-oxide portends high mortality risk independent of glycemic control in patients with type 2 diabetes mellitus. Clinical chemistry, 63 (1), 297–306.
   PubMed Web of Science ®Google Scholar
• Thomas, M.C., et al., 2003. Reduced tubular cation transport in diabetes: prevented by ACE inhibition. Kidney international, 63 (6), 2152–2161.
   PubMed Web of Science ®Google Scholar
• Tomasova, L., et al., 2016. Intracolonic hydrogen sulfide lowers blood pressure in rats. Nitric oxide, 60, 50–58.
   PubMed Web of Science ®Google Scholar
• Ufnal, M., et al., 2014. Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats. Canadian journal of cardiology, 30 (12), 1700–1705.
   PubMed Web of Science ®Google Scholar
• Yancey, P.H., 2005. Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses. Journal of experimantal biology, 208 (Pt 15), 2819–2830.
   Web of Science ®Google Scholar
• Yang, T., et al., 2015. Gut dysbiosis is linked to hypertension. Hypertension, 65 (6), 1331–1340.
   PubMed Web of Science ®Google Scholar
• Zeisel, S.H., et al., 1989. Conversion of dietary choline to trimethylamine and dimethylamine in rats: dose-response relationship. The journal of nutrition, 119 (5), 800–804.
   PubMed Web of Science ®Google Scholar